PANCREATIC ADENOCARCINOMA METASTATIC
Clinical trials for PANCREATIC ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new weapon to stop deadly pancreatic Cancer's defenses
Disease control OngoingThis study is testing if adding two experimental drugs to standard chemotherapy can prevent advanced pancreatic cancer from becoming resistant to treatment. The goal is to help the standard drugs work better and for longer. The study will involve about 70 adults with newly diagno…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Scientists launch bold attack on advanced pancreatic cancer with 7-Drug cocktail
Disease control OngoingThis early-stage study is testing a new, intensive combination of treatments for people with metastatic pancreatic cancer who have not yet received any therapy. The goal is to see if adding two new immune-based drugs (botensilimab and balstilimab) to a strong chemotherapy regimen…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC